Literature DB >> 18776868

Hope in Alzheimer's fight emerges from unexpected places.

Trisha Gura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18776868     DOI： 10.1038/nm0908-894

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  34 in total

1.  Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity.

Authors:  David X Medina; Antonella Caccamo; Salvatore Oddo
Journal:  Brain Pathol       Date:  2011-03       Impact factor: 6.508

2.  Do amyloid-lowering strategies work clinically?

Authors:  Rob J van Marum
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

3.  Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Tatsuya Segawa; Masahiro Maeda; Nobuhiro Maruyama; Noriaki Kinoshita; Huayan Hou; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

4.  Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways.

Authors:  Ali Reza A Ladiwala; Jonathan S Dordick; Peter M Tessier
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

Review 5.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 6.  Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.

Authors:  Sarawut Suksuphew; Parinya Noisa
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 7.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

8.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

9.  Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action.

Authors:  Tatyana Strekalova; Nataliia Bahzenova; Alexander Trofimov; Angelika G Schmitt-Böhrer; Nataliia Markova; Vladimir Grigoriev; Vladimir Zamoyski; Tatiana Serkova; Olga Redkozubova; Daria Vinogradova; Alexei Umriukhin; Vladimir Fisenko; Christina Lillesaar; Elena Shevtsova; Vladimir Sokolov; Alexey Aksinenko; Klaus-Peter Lesch; Sergey Bachurin
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

10.  Alzheimer's disease therapeutic research: the path forward.

Authors:  Paul S Aisen
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.